Seppo Pyrhönen

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

David Cunningham, Seppo Pyrhönen, R.D. James et al. · The Lancet · 1998 · 1.3K citations

Gastrointestinal Oncology, Medicine, Cancer Management +6

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

Seppo Pyrhönen, Tapio Kuitunen, Paul Nyandoto et al. · British Journal of Cancer · 1995 · 794 citations · Full text

Surgical Oncology, Oncology, Gastrointestinal Oncology +6

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2012 · 527 citations

Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis

Karí Syrjänen, Stina Syrjänen, Matti A. Lamberg et al. · International Journal of Oral Surgery · 1983 · 464 citations

Immunohistochemical Evidence, Human Papillomavirus Vaccines, Oral Cavity +10

Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell Cancer

Seppo Pyrhönen, Eeva Salminen, Mirja Ruutu et al. · Journal of Clinical Oncology · 1999 · 441 citations